Resumen
En este trabajo se revisa el concepto de calidad de vida relacionada con la salud, su definición, su composición, su medición y su utilización. Se enfatizan el hecho de que se trata de un concepto compuesto por varias dimensiones y los problemas que entraña su interpretación debido a este hecho. La CVRS es uno de los conceptos más consolidados dentro de la IRS; permite incorporar con facilidad la perspectiva del paciente a los estudios médicos y, en especial, a los fármaco-económicos.
Bibliografía
Bungay K, Boyer JG, Steinwald AB, Ware JE. Health-Related Quality of Life: An Overview. En: Bootman JL, Townsend RJ, McGhan WF. Principles of Pharmacoeconomics 2nd edition. Cincinati: Harvey Whitney Books Company, 1996
Bulpit CJ. Quality of life as an outcome measure. Postgrad Med J 1997; 73: 613–6
Kind P. The Role of Quality of Life Measurement in Economic Evaluation: Lessons from the National Health Service. En: Pinto JL, López-Casanovas, Ortún V. (Eds). Economic Evaluation: From theory to practice. Barcelona: Spinger-Verlag Ibérica, 2001
Shikiar R, Rentz A. Satisfaction with medication: An overview of conceptual, methodological, and regulatory issues. ISPOR 2004; 7: 204–15
Badía X. ¿Qué es Satisfacción y Preferencias con el tratamiento? Madrid; Departamento de Farmacoeconomía, Roche, 2005
Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74
Albrecht G, Hoogstraten J. Satisfaction as a determinant of compliance. Community Dentistry and Oral Epidemiology 1998; 26: 139–46
Ruiz, MA, Villasante F, León F, González-Lara V, González C, Crespo M, Rejas J, Soto J. Cuestionario sobre calidad de vida asociada a dispepsia. Adaptación española y validación del cuestionario Dyspepsia Related Health Scale. Med Clin 2001; 117: 567–73
Richard M, Reig A, Cabrero J. La Calidad de vida en la vejez. Sus determinantes biológicos, psicológicos y sociales. Alicante: Editorial Club Universitario, 1999
Guyatt GH, Veldhuyzen van Zanten SJO, Feeny DH, Patrick DL. Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J 1989; 140: 1441–8
Badía X, Salamero M, Alonso J. La medida de la salud. Guía de escalas de medición en español. Barcelona: Edimac, 2002
Red IRYSS. http://www.rediryss.net/pub/units/rediryss/html/es/ dir279/index.html. Línea de investigación 3.2. [Acceso 8 marzo 2005]
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute, 1993
Alonso J, Prieto L, Antó JM. Versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de resultados clínicos. Med Clin 1995; 104: 771–6
Ware JE, Kosinski M, Keller SD. A 12 Item Sort-Form Health Survey. Construction of Scales and Preliminary Tests of Reliability and Validity. Med Care 1996, 34: 220–33
Brooks R et al. EuroQol: The current state of play. Health Policy 1996; 37: 53–72
Badía X, Roset M, Montserrat S, Herdman M, Segura A. La versión española del EuroQoL: descripción y aplicaciones. Med Clin 1999; 112(Supl 1): 79–86
Hunt SM. Nottingham Health Profile. In: Wenger NK, Mattson ME, Furberg CD, Elison J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Washington DC: Le Jacq Press, 1984
Barry MJ, Fowler JR, O’leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK and the Measurement committee of the American Urological Association: The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 1992; 148: 1549–57
Bellamy N, Buchanan WW. Outcome measurement in osteoarthritis clinical trials: the case of standardisation. Clinical Rheumatology 1984; 3: 193–303
Kuykendall DH, Rabeneck L, Campbell CJM, Wray NP. Dyspepsia: how should we measure it? J Clin Epidemiol 1998; 51: 99–106
Cook KF, Rabeneck L, Campbell CJM, Wray NP. Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial. J Clin Epidemiol 1999; 52: 381–92
Jones PW, Quirck FH, Baveystock CM. The St Georges’s Respiratory Questionnaire. Respiratory Medicine 1991; 85: 25–31
Wu AW, Rubin HR, Mathews WC, Ware JE, Brysk LT, Hardy WD, Bozzette SA, Spector SA, Richman DD. A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Med Care 1991; 29(8): 786–98
Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care 1998; 36: 126–37
Diabetes Control and Complications Trial (DCCT). Reliability and Validity of a Diabetes Quality of Life Measure for the diabetes Control and Complications Trial (DCCT). Diabetes Care 1988; 11: 725–32
Badía X. The use of Quality of Life Instruments in Health Surveys: their Relevance for Decision-Making. En: Pinto JL, López-Casanovas, Ortún V. (Eds). Economic Evaluation: From theory to practice. Spinger-Verlag Ibérica, 2001
Fernández Ballesteros R, Maciá A. Calidad de vida en la vejez. Intervención Psicosocial 1983; 2: 77–94
Montorio I, Izal M. Successful aging. But, why don’t the elderly get more depressed? Psychology in Spain 1998; 2: 27–46
Fernández-Ballesteros R, Zamarrón MD, Ruiz MA. The contribution of socio-demographic and psychosocial factors to life satisfaction. Ageing and Society 2001: 21; 25–43
Black D, Morris JN, Smith C & Townsend P. Inequalities in health. The Black Report, Middlesex, Penguin Books, 1982
Wilkin D. Conceptual problems in dependency research. Social Science and Medicine 1987; 24: 867–73
Bowling A. Measuring health: a review of quality of life measurement scales. Open University Press, 1992
Izal M, Montorio I. Determinantes del Bienestar Psicológico en la Vejez. Rev Argentina Psicol Clínica 1993; 2: 147–59
Testa MA, Simmonson DC. Assessment of quality of life outcomes. N Eng J Med 1996; 334: 835–40
Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000; 9: 887–900
Papani colaou S, Sykes D, Mossaialos E. EMEA and the evaluation of health-related quality of life data in the drug regulatory process. Int J health Tecn Assess Health Care 2004; 20: 311–24
National Center of Biotechnology Information. http://www.ncbi.nlm.nih.gov/ [Acceso 8 de marzo de 2005]
Croog SH, Levine S, Testa MA et al. The effects of antihypertensive therapy on the quality of life. N Eng J Med 1986; 314: 1657–64
Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81–7
Alonso J. La medida de la calidad de vida relacionada con la salud en la investigación y la práctica clínica. Gac Sanit 2000; 14: 163–7
Rumsfeld JS, Whinney SM, McCarthy M, et al. health-Related Quality of Life as a Predictor of Mortality Following Coronary Artery Bypass Graft Surgery. JAMA 1999; 281: 1298–1303
Krumholz HM, Mchorney CA, Clark L, et al. Changes in health after elective percutaneous coronary revascularization. Med Care 1996; 34: 754–9
Permanyer-Miralda G, Alonso J, Antó JM, et al. Comparison of perceived health status and conventional functional evaluation in stable patients with coronary artery disease. J Clin Epidemiol 1991; 44: 779–86
Cyr PL, Lenhart G. Short form SF-12 as a predictor of healthcare expenditure in individuals over 65 years of age. Medical Decision Making 1998; 4: 459
Miilunpalo S, Vuori I, Oja P, et al. Self-rated health status as a health measure: The predictive value of self-reported health status on the use of physician services and on mortality in the working-age population. J Clin Epidemiol 1997; 5: 517–28
Lundberg L, Johannesson M, Isacson D, et al. The relationship between Health-state utilities and the SF-12 in a General Population. Med Decis Making 1999; 19: 128–40
Furlong W, Feeny D, Torrance G, Goldsmith C, DePauw S, Zhu Z, Denton M, Boyle M. Multiplicative Multi-Attribute Utility Function for the Health Utilities Index Mark3 (HUI3) System: A Technical Report. Hamilton: McMaster University Center for Health Economics and Policy Analysis, 1998
Dolan P. Modelling Valuations for EuroQoL Health States. Med Care 1997; 35: 1095–1108
Ruiz MA, Rejas J, Soto J, Pardo A, Rebollo I. Adaptación y validación del Health Utilities Index Mark 3 al castellano y baremos de corrección en la población Española. Med Clín 2003; 120: 89–96.
Ruiz MA, Rebollo I, Bermejo F, Rejas J. Adaptation of the HUI-MARK3 to elder population. 10th Annual Conference of the International Society for Quality of Life Research (ISOQOL). Prague, 2003
Nord E. Measuring Population Health: an Organisation for Economic Cooperation and Development Survey of Multi-Attribute Utility Instruments. En: Pinto JL, López-Casanovas, Ortún V (Eds.). Economic Evaluation: From theory to practice. Barcelona: Spinger-Verlag Ibérica, 2001
Badía X. Sobre la adaptación transcultural de medidas de calidad de vida relacionada con la salud para uso en España. Med Clin 1995; 105: 56–8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruiz, M.A., Pardo, A. Calidad de vida relacionada con la salud: definición y utilización en la práctica médica. Pharmacoecon. Span. Res. Artic. 2, 31–43 (2005). https://doi.org/10.1007/BF03320897
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03320897